InTandem Capital Partners, a healthcare services focused private equity firm, completed the investment in Adams Clinical, a clinical trial site network with locations across the Northeast that conducts independent evaluations of drugs to treat psychiatric and neurologic illnesses. Financial terms were not disclosed. "We are excited to have InTandem Capital’s help growing Adams. We value InTandem’s integrated investment and operating strategy, which is tailored for companies like ours at an inflection point. The InTandem team’s wealth of industry knowledge will enable us to develop a world-class site network that benefits both our pharmaceutical company customers and the patients who ultimately are prescribed drugs we tested," Nelson Rutrick, Adams Clinical CEO.